Today: 31 January 2026
Subscribe
Browse Category

Investment News News 16 October 2025 - 20 October 2025

Navitas (NVTS) Stock Skyrockets on NVIDIA AI Chip News — Record Rally Sparks Bull-Bear Debate

Navitas Semiconductor Stock Skyrockets on AI Chip Buzz – NVTS Hits Record High Amid GaN Frenzy

NVTS Stock Extends Rally to Record High Navitas’s stock continued its blistering ascent on Monday, October 20, 2025, touching an intraday high of $17.79 (a fresh 52-week peak) before closing around $17.06 Stockanalysis. That marks the highest level in the company’s trading history. Shares are now up over 330% in 2025 – a remarkable run from roughly $4 at the…
20 October 2025
····
Nuclear SPAC Stock Skyrockets: Terrestrial Energy’s SPAC Deal Ignites Investor Frenzy

Nuclear SPAC Stock Skyrockets: Terrestrial Energy’s SPAC Deal Ignites Investor Frenzy

Terrestrial Energy is a Generation-IV nuclear developer known for its IMSR technology ts2.tech Businesswire. The IMSR is a modular molten-salt reactor that uses low-enriched uranium; it is inherently safe thanks to its fuel salt and temperature control design ts2.tech Globenewswire. Terrestrial has been building regulatory momentum: besides the recent NRC ruling, Canada’s regulator completed a positive Vendor Design Review in…
20 October 2025
··
Sellas Life Sciences (SLS) Stock Skyrockets: BlackRock’s 5% Bet and Breakthrough Cancer Data Ignite Rally

Sellas Life Sciences (SLS) Stock Skyrockets: BlackRock’s 5% Bet and Breakthrough Cancer Data Ignite Rally

Sellas Life Sciences (NASDAQ: SLS) stock has surged roughly 100% year-to-date, closing around $2.14 on Oct. 17, 2025 ts2.tech ts2.tech (versus a 52-week low of $0.77). In after-hours trading on Oct. 17 it spiked another +38%, briefly touching a new 52-week high ts2.tech. Big investors are piling in: BlackRock disclosed a 5.4% stake (~5.7M shares) in SLS on Oct. 18…
20 October 2025
····
Summit Therapeutics (SMMT) Skyrockets on Cancer Breakthrough – Key Facts & Outlook

Summit Therapeutics (SMMT) Skyrockets on Cancer Breakthrough – Key Facts & Outlook

SMMT Stock’s Wild Ride in 2025 Summit Therapeutics’ share price has been on a roller-coaster ride this year. After a steady climb through late summer, SMMT spiked above $25 intraday in mid-October, then pulled back to end last week just under $21 ts2.tech. The stock fell 4.5% on Friday, Oct. 17 alone ts2.tech as traders braced for the upcoming data…
20 October 2025
···
Rani Therapeutics (RANI) Stock Skyrockets ~200% on $1B Pharma Deal – Will the Rally Last?

Rani Therapeutics (RANI) Stock Skyrockets ~200% on $1B Pharma Deal – Will the Rally Last?

RANI Stock Price Skyrockets on Deal News Rani’s stock price skyrocketed after the company unveiled its landmark partnership and financing news. On Friday, Oct. 17, 2025, RANI opened around $1.37 and surged as high as $2.39 intraday before settling at a $1.64 closing price – a stunning +248% one-day gain Investing. The prior day, RANI had closed at just $0.47,…
20 October 2025
····
Broadcom’s AI Windfall: Inside AVGO’s Trillion-Dollar Surge, $10B Chip Deal & 2025 Outlook

Broadcom (NASDAQ: AVGO): What to Know Before Markets Open on October 20, 2025

Broadcom’s AI Jackpot: Stock Soars on OpenAI Deal as Analysts Bet Big on AVGO Broadcom Stock on a Tear, Fueled by AI Hype Broadcom’s stock has been on a remarkable tear in 2023–2025, reaching trillion-dollar territory as it rides the wave of AI optimism. After a 10-for-1 stock split in February 2024 (which made shares more affordable to retail investors),…
19 October 2025
····
Battle of the EV Charging Standards: Tesla’s NACS vs. CCS2 vs. CHAdeMO – Who Will Rule the Roads in 2025?

Tesla Stock’s Wild Ride: TSLA Soars on Record Sales, Sinks on ‘Budget’ EV News – What’s Next?

Tesla Stock on Oct 18: Recent Performance As of this weekend (Oct. 18, 2025), Tesla’s stock is hovering in the high-$420s per share, just shy of the peaks it hit earlier in the month ts2.tech. On Oct. 6, TSLA reached roughly $453, a 52-week high, before pulling back amid profit-taking ts2.tech. The past week saw notable volatility: shares jumped about…
18 October 2025
····
GRAIL (GRAL) Stock Skyrockets on Samsung’s $110M Bet and Cancer-Screening Breakthrough

GRAIL (GRAL) Stock Skyrockets on Samsung’s $110M Bet and Cancer-Screening Breakthrough

GRAIL’s logo at company headquarters. The Menlo Park biotech specializes in blood-based early cancer screening through its Galleri test Samsung Tradingview. GRAIL, Inc. is focused on early cancer detection – its mission is “to detect cancer early when it can be cured” Samsung. The company’s Galleri test analyzes tumor DNA in blood to screen for dozens of cancers in asymptomatic…
18 October 2025
····
GE Aerospace Stock Rockets as Rally Continues – Q3 Earnings, Contracts, and Analyst Targets in Focus

GE Aerospace Stock Rockets as Rally Continues – Q3 Earnings, Contracts, and Analyst Targets in Focus

Surging Stock Performance GE Aerospace (NYSE: GE) shares have been on a tear in 2025, roughly doubling from lows. As of Oct 17, 2025, the stock closed around $300 Reuters. That’s up about 78% this year Intelligentinvestor – one of the best performances among mega-cap industrials. The 52-week high is $307.25 and the low was $159.36 Reuters, reflecting a remarkable…
18 October 2025
····
BigBear.ai (BBAI) Stock Rockets 80% in 2025 – Is the Defense-AI Rally Just Beginning?

BigBear.ai’s Stock Skyrockets on Defense AI Deals – Is BBAI the Next Palantir? 🚀

Stock Price Soars Amid Defense AI Boom BigBear.ai’s stock has been on a tear in October as investors pile into defense-focused AI names. On October 13, shares spiked 22% in a single day after the company announced a new AI partnership, leaping from the mid-$7 range to about $8.80 ts2.tech. It was BBAI’s biggest one-day jump in over a year.…
18 October 2025
···
Interactive Brokers Stock Soars After Q3 Earnings Beat, 40% Asset Surge

Interactive Brokers Stock Soars After Q3 Earnings Beat, 40% Asset Surge

Interactive Brokers Group (NASDAQ: IBKR) is making headlines after delivering standout third-quarter results on October 16, 2025, which sent its stock into focus. The online brokerage reported earnings and revenue that topped analyst expectations, fueling optimism among investors. IBKR’s shares closed at $68.52 after the earnings release – marking an impressive rise of about 83% over the past 12 months…
17 October 2025
···
Femasys (FEMY) Stock Soars 46% on Fertility Tech and FDA Milestones

Femasys (FEMY) Stock Soars 46% on Fertility Tech and FDA Milestones

Femasys’ stock surge on Oct. 16 mirrors growing investor interest in its reproductive healthcare pipeline. The company’s FemaSeed™ technology is designed to boost pregnancy rates by delivering sperm directly into the fallopian tube, and published trials report more than double the pregnancy rate of traditional intrauterine insemination Globenewswire Stocktitan. Femasys is positioning FemaSeed as a first-line, lower-cost infertility option ahead of IVF. Meanwhile, FemBloc…
16 October 2025
···
1 … 183 184 185 186 187 … 191

Stock Market Today

  • Top 2 AI Stocks Powering the Agentic AI Market Surge
    January 31, 2026, 6:38 AM EST. The agentic AI market is set to soar nearly tenfold by 2030, reaching $24 billion from $2.6 billion in 2024, according to Grand View Research. UiPath (PATH) and Alphabet (GOOGL) are leading players building the core infrastructure and platforms. UiPath integrates AI agents into enterprise workflows, turning profitable with a recent operating profit of $13 million and trading at a discounted valuation. Alphabet powers the backbone with its AI model Gemini, used by over 650 million monthly users, processing more than 7 billion tokens per minute. Google's broad industry applications and robust infrastructure position it to benefit from growing AI adoption across sectors.
Go toTop